High serum oestradiol concentrations in IVF cycles increase the risk of pregnancy complications related to abnormal placentation
Abstract
The study was designed to evaluate the isolated effect of high serum oestradiol concentration on human chorionic gonadotrophin (HCG) day in IVF cycles on endometrial receptivity and placentation. A retrospective cohort included all women attending the IVF unit in 2006 and 2007, with the best prognosis to achieve pregnancy: age (<38
years), less than three IVF cycles, transfer of two highest grade embryos and no evidence of factors known to impair implantation or that are associated with increased risk of pregnancy complications. The total included 280 patients were categorized into three groups according to their serum oestradiol concentration on HCG day: group 1, oestradiol <5000
pmol/l, group 2, oestradiol in the range 5000–10,000
pmol/l and group 3, oestradiol in the range of 10,000–15,000
pmol/l. No significant differences were found between the groups in implantation, pregnancy and abortion rates. The high oestradiol group was characterized by high rate (20.8%) of pregnancy complications related to abnormal placentation – fetal growth restriction, pregnancy-induced hypertension and abnormal implantation of the placenta. Hence, the decision to perform embryo transfer in high-responder patients should take into consideration both possible risks of ovarian hyperstimulation syndrome and pregnancy complications related to abnormal placentation.
Keywords: implantation, IVF, oestradiol concentrations, placentation, pregnancy complications
To access this article, please choose from the options below
Jacob Farhi received his MD from the Tel Aviv University in 1987. He is a senior lecturer at the Sackler School of Medicine, Tel Aviv University. He works as a senior consultant physician in the IVF and Infertility Unit at the Rabin Medical Centre. Currently his research interests are in the fields of follicular regulation in the human fetal ovaries and in clinical aspects of ovulation induction, IVF and in-vitro maturation treatments.
PII: S1472-6483(10)00234-8
doi:10.1016/j.rbmo.2010.04.022
© 2010 Reproductive Healthcare Ltd. Published by Elsevier Inc All rights reserved.
Refers to erratum:
- Erratum to “High serum oestradiol concentrations in IVF cycles increase the risk of pregnancy complications related to abnormal placentation” [Reprod. BioMed. Online 21 (2010) 331–337] , 28 September 2010
